Markets open

Centene Corporation

CNC · NYSE

Analyst Consensus

Hold

20 analysts

$66

Current

—

Low

$71

Average

—

High

Average target implies +6.07% versus the current price.

The ratings synthesis for CNC has not been generated yet.

Rating Actions

No individual rating actions have been captured for CNCyet. Consensus figures above come from Nasdaq's aggregate feed.

Rating actions are extracted from published reporting. Each row links to its source.

Covering Firms

ARGUS RESEARCH

B OF A GLBL RES

BARCLAYS CAPITA

CANTOR FITZGERA

CO FORECST

DEUTSCHE BK SEC

GOLDMAN SACHS

JEFFERIES & CO.

JP MORGAN SECUR

LOOP CAPITAL MK

MIZUHO SECURITI

OPPENHEIMER HLD

SANFORD BERNSTE

STEPHENS INC

TD COWEN

TRUIST SECURITI

UBS

WELLS FARGO SEC

WOLFE RESEARCH

ZACKS RESEARCH

Symbol: CNC
Type: Stock
Sector: Health Care
Industry: Medical Specialities
Country: North America
Exchange: NYSE

Centene Corporation, a Fortune 500 company, is a leading healthcare enterprise that is committed to helping people live healthier lives. The Company takes a local approach with local teams to provide fully integrated, high-quality, and cost-effective services to government-sponsored and commercial healthcare programs, focusing on under-insured individuals. Centene offers affordable and high-quality products to more than 1 in 15 individuals across the nation, including Medicaid and Medicare members (including Medicare Prescription Drug Plans) as well as individuals and families served by the Health Insurance Marketplace.